This post was originally published on this site
The pharmaceutical giant’s closing price was $51.71 below its 52-week high of $601.84, achieved on September 14, 2023. In comparison to other companies in the same sector on Thursday, Eli Lilly & Co.’s performance was less impressive. For instance, Johnson & Johnson (NYSE:JNJ) experienced a lesser decline of 0.77%, with its shares closing at $161.66.
In addition to the decline in share value, another significant aspect of Thursday’s trading was the volume of shares traded for Eli Lilly & Co., which stood at 4 million, surpassing its 50-day average trading volume of 2.9 million.
The data for this report is derived from information provided by Dow Jones and FactSet, as part of an automated analysis by a technology provider specializing in market data automation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
